Literature DB >> 9475661

Structural and mechanistic aspects of Janus kinases: how the two-faced god wields a double-edged sword.

R J Duhé1, W L Farrar.   

Abstract

The Janus family of protein-tyrosine kinases has long been known to function in signal transduction pathways initiated by a host of cytokines. A brief overview of the role of Janus kinases (Jaks) in both cytokine and noncytokine signaling pathways highlights the broad physiologic importance of this kinase family. New insights into the structural and mechanistic regulatory aspects of Janus kinases are rapidly emerging. Recent mutational analyses allow the dissection of Jaks into three distinct structural domains governing receptor affiliation, autoregulation, and catalysis. A fourth domain determining substrate specificity is as yet poorly defined and is, therefore, discussed in the context of known substrates and inhibitors, a collection of molecules that have been expanded recently to include Stam and Jab. The proposed mechanism of the interconversion of Janus kinases from inactive to fully active enzymes involves three states of enzymatic activity. Additional layers of regulation can be independently superimposed on this multistate model, providing a simplified description of the behavior of Janus kinases under normal and pathologic circumstances.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9475661     DOI: 10.1089/jir.1998.18.1

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  8 in total

1.  Nuclear export signal located within theDNA-binding domain of the STAT1transcription factor.

Authors:  K M McBride; C McDonald; N C Reich
Journal:  EMBO J       Date:  2000-11-15       Impact factor: 11.598

Review 2.  Role of the JAK/STAT signal transduction pathway in the regulation of gene expression in CNS.

Authors:  P Dell'Albani; R Santangelo; L Torrisi; V G Nicoletti; A M Giuffrida Stella
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

3.  STAT1 from the cell membrane to the DNA.

Authors:  B F Lillemeier; M Köster; I M Kerr
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

Review 4.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

5.  Characterization of the in vitro kinase activity of a partially purified soluble GST/JAK2 fusion protein.

Authors:  Roy J Duhé; Emily A Clark; William L Farrar
Journal:  Mol Cell Biochem       Date:  2002-07       Impact factor: 3.396

6.  Mutation of glutamic acid residue 1046 abolishes Jak2 tyrosine kinase activity.

Authors:  Dannielle VonDerLinden; Xianyue Ma; Eric M Sandberg; Kim Gernert; Kenneth E Bernstein; Peter P Sayeski
Journal:  Mol Cell Biochem       Date:  2002-12       Impact factor: 3.842

7.  The expression profiles of immune genes in Mus musculus macrophages during Staphylococcus aureus infection.

Authors:  Ziyan Wang; Fei Zhu
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

Review 8.  Basic Mechanisms of JAK Inhibition.

Authors:  Chung Ma Lin; Faye Ah Cooles; John D Isaacs
Journal:  Mediterr J Rheumatol       Date:  2020-06-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.